4Durongpisitkul K,Gururaj VJ,Park JM,et al.The prevention of coronary artery aneurysm in Kawasaki disease:a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.Pediatrics,1995,96:1057-1061.
5Muta H,Ishii M,Egami K.Early intravenous gamma-globulin treatment for Kawasaki disease:the nationwide surveys in Japan.J Pediatr,2004,144:496-499.
6Sundel RP,Baker AL,Fulton DR,et al.Corticosteroids in the initial treatment of Kawasaki disease:report of a randomized trial.J Pediatr,2003,142:611-616.
7Oki I,Tanihara S,Ojima T,et al.A multicenter collaborative study on the risk factors of cardiac sequelae due to Kawasaki disease:a one-year follow-up study.Acta Pediatr,2000,89:1435-1438.
8Sato N,Sugimura T,Akagi T,et al.Selective high dose gamma-globulin treatment in Kawasaki disease:assessment of clinical aspects and cost effectiveness.Pediatr Int,1999,41:1-7.
4Curtis N,Zhong R,lamb JR,et al.Evidence for a superantigen mediated process in Kawasaki disease[J].Arch Dis Child,1995,72:308-311.
5Furukawa S,Matsubara T,Umezawa,et al.Serum levels of P60 Soluble tumor necrosis factor receptor during Acute Kawasaki disease[J].J pediatr,1998,124:721-725.
6Barron KS,Shulman ST,Rowley AH,et al.Report of the National Institutes of Health Workshop on Kawasaki disease[J].J Rheumatology,1999,26:170-177.
7Tizard EJ, Suzuki A, Levin MC, et al. Clinical aspects of 100 patients with Kawasaki disease[J]. Arch Dis Chikt, 1997,78(2):183-191.
8Newburger JW, Takahashi M, Beiser AS. A single intravenous infusion of gammaglobulin as compared with lour infusion in the treatment of acute Kawasaki disease[J]. New Engl J Med,1991,324:1633-1639.
9Dhillon R, Newtn L, Rudd PT, et al. Management of Kawasaki disease in the British Isles[J]. Arch Dis Child,1993,69(6):631-640.
